Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc. operates in various business sectors.
Market Cap & Net Worth: Aldeyra Therapeutics Inc. (137)
Aldeyra Therapeutics Inc. (BE:137) has a market capitalization of $42.13K (€41.04K) as of March 19, 2026. Listed on the BE stock exchange, this Germany-based company holds position #42660 globally and #6700 in its home market, demonstrating a -3.07% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aldeyra Therapeutics Inc.'s stock price €4.42 by its total outstanding shares 9287 (9.29K).
Aldeyra Therapeutics Inc. Market Cap History: 2020 to 2025
Aldeyra Therapeutics Inc.'s market capitalization history from 2020 to 2025. Data shows growth from $53.86K to $42.13K (1.34% CAGR).
Aldeyra Therapeutics Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aldeyra Therapeutics Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 137 by Market Capitalization
Companies near Aldeyra Therapeutics Inc. in the global market cap rankings as of March 19, 2026.
Key companies related to Aldeyra Therapeutics Inc. by market ranking:
- Chablis Capital Corp. (V:CCZ-P): Ranked #42651 globally with a market cap of $41.55K USD ( CA$59.67K CAD).
- ROYAL MAIL (BE:RYE): Ranked #42652 globally with a market cap of $41.47K USD ( €40.40K EUR).
- BLE KEDROS REIC EO 1 (F:N67): Ranked #42661 globally with a market cap of $41.23K USD ( €40.17K EUR).
- Hoteles Bestprice S.A. (PA:MLHBP): Ranked #42662 globally with a market cap of $41.18K USD ( €40.12K EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #42651 | Chablis Capital Corp. | V:CCZ-P | $41.55K | CA$0.06 |
| #42652 | ROYAL MAIL | BE:RYE | $41.47K | €4.26 |
| #42661 | BLE KEDROS REIC EO 1 | F:N67 | $41.23K | €4.11 |
| #42662 | Hoteles Bestprice S.A. | PA:MLHBP | $41.18K | €4.04 |
Aldeyra Therapeutics Inc. Historical Marketcap From 2020 to 2025
Between 2020 and today, Aldeyra Therapeutics Inc.'s market cap moved from $53.86K to $ 42.13K, with a yearly change of 1.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €42.13K | -9.22% |
| 2024 | €46.41K | +50.25% |
| 2023 | €30.89K | -50.97% |
| 2022 | €62.99K | +87.73% |
| 2021 | €33.56K | -37.70% |
| 2020 | €53.86K | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Aldeyra Therapeutics Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $42.13K USD |
| MoneyControl | $42.13K USD |
| MarketWatch | $42.13K USD |
| marketcap.company | $42.13K USD |
| Reuters | $42.13K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.